SpineFrontier earns FDA approval for A-CIFT SoloFuse HA Standalone System: 3 things to know

SpineFrontier earned FDA approval for its A-CIFT SoloFuse HA fusion technology.

Advertisement

Here are three things to know:

1. The A-CIFT SoloFuse HA standalone system is designed to offer an alternative to traditional plating.

2. The system features PEEK-OPTIMA with hydroxyapetite. Invibio’s biomaterial PEEK-OPTIMA HA Enhanced is designed to promote bone formation and high-quality new bone bridging.

3. When used with SpineFrontier’s angled driver technology, the A-CIFT SoloFuse HA is intended to limit tissue disruption.

More articles on surface technology:
Centinel Spine receives FDA 510(k) clearance for its FLX Platform of 3D-printed all-titanium devices: 4 insights
Camber Spine receives FDA clearance for titanium ALIF device: 3 insights
Oxford Performance Materials teams up with JSR Corp. to advance PEKK line in Asia: 4 insights

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.